286 related articles for article (PubMed ID: 19263430)
1. In vitro toxicity testing of nanoparticles in 3D cell culture.
Lee J; Lilly GD; Doty RC; Podsiadlo P; Kotov NA
Small; 2009 May; 5(10):1213-21. PubMed ID: 19263430
[TBL] [Abstract][Full Text] [Related]
2. Engineering liver tissue spheroids with inverted colloidal crystal scaffolds.
Lee J; Cuddihy MJ; Cater GM; Kotov NA
Biomaterials; 2009 Sep; 30(27):4687-94. PubMed ID: 19524294
[TBL] [Abstract][Full Text] [Related]
3. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
4. Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles.
Chia SL; Tay CY; Setyawati MI; Leong DT
Small; 2015 Feb; 11(6):702-12. PubMed ID: 25331163
[TBL] [Abstract][Full Text] [Related]
5. Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing.
Cui ZF; Xu X; Trainor N; Triffitt JT; Urban JP; Tirlapur UK
Toxicol In Vitro; 2007 Oct; 21(7):1318-24. PubMed ID: 17640847
[TBL] [Abstract][Full Text] [Related]
6. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
[TBL] [Abstract][Full Text] [Related]
7. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.
Yoshii Y; Waki A; Yoshida K; Kakezuka A; Kobayashi M; Namiki H; Kuroda Y; Kiyono Y; Yoshii H; Furukawa T; Asai T; Okazawa H; Gelovani JG; Fujibayashi Y
Biomaterials; 2011 Sep; 32(26):6052-8. PubMed ID: 21640378
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines.
Bregoli L; Chiarini F; Gambarelli A; Sighinolfi G; Gatti AM; Santi P; Martelli AM; Cocco L
Toxicology; 2009 Aug; 262(2):121-9. PubMed ID: 19482055
[TBL] [Abstract][Full Text] [Related]
9. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
Lama R; Zhang L; Naim JM; Williams J; Zhou A; Su B
Bioorg Med Chem; 2013 Feb; 21(4):922-31. PubMed ID: 23306053
[TBL] [Abstract][Full Text] [Related]
10. A new approach to the toxicity testing of carbon-based nanomaterials--the clonogenic assay.
Herzog E; Casey A; Lyng FM; Chambers G; Byrne HJ; Davoren M
Toxicol Lett; 2007 Nov; 174(1-3):49-60. PubMed ID: 17920791
[TBL] [Abstract][Full Text] [Related]
11. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
Yip D; Cho CH
Biochem Biophys Res Commun; 2013 Apr; 433(3):327-32. PubMed ID: 23501105
[TBL] [Abstract][Full Text] [Related]
12. Discriminative cytotoxicity assessment based on various cellular damages.
Kim H; Yoon SC; Lee TY; Jeong D
Toxicol Lett; 2009 Jan; 184(1):13-7. PubMed ID: 18992794
[TBL] [Abstract][Full Text] [Related]
13. The effects of serum on the toxicity of manufactured nanoparticles.
Clift MJ; Bhattacharjee S; Brown DM; Stone V
Toxicol Lett; 2010 Oct; 198(3):358-65. PubMed ID: 20705123
[TBL] [Abstract][Full Text] [Related]
14. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays.
Lison D; Thomassen LC; Rabolli V; Gonzalez L; Napierska D; Seo JW; Kirsch-Volders M; Hoet P; Kirschhock CE; Martens JA
Toxicol Sci; 2008 Jul; 104(1):155-62. PubMed ID: 18400775
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs.
Ho WJ; Pham EA; Kim JW; Ng CW; Kim JH; Kamei DT; Wu BM
Cancer Sci; 2010 Dec; 101(12):2637-43. PubMed ID: 20849469
[TBL] [Abstract][Full Text] [Related]
16. Surface properties and behavior of lipid extracts from plasma membranes of cells cultured as monolayer and in tissue-like conditions.
Jordanova A; Stefanova N; Staneva G; Pankov R; Momchilova A; Lalchev Z
Cell Biochem Biophys; 2009; 54(1-3):47-55. PubMed ID: 19484199
[TBL] [Abstract][Full Text] [Related]
17. Energy metabolism and biotransformation as endpoints to pre-screen hepatotoxicity using a liver spheroid model.
Xu J; Purcell WM
Toxicol Appl Pharmacol; 2006 Oct; 216(2):293-302. PubMed ID: 16828827
[TBL] [Abstract][Full Text] [Related]
18. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
[TBL] [Abstract][Full Text] [Related]
19. Drug testing on 3D in vitro tissues trapped on a microcavity chip.
Kloss D; Fischer M; Rothermel A; Simon JC; Robitzki AA
Lab Chip; 2008 Jun; 8(6):879-84. PubMed ID: 18497906
[TBL] [Abstract][Full Text] [Related]
20. Agar-gelatin hybrid sponge-induced three-dimensional in vitro 'liver-like' HepG2 spheroids for the evaluation of drug cytotoxicity.
Verma P; Verma V; Ray P; Ray AR
J Tissue Eng Regen Med; 2009 Jul; 3(5):368-76. PubMed ID: 19408239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
